Predictors of recurrence of ovarian granulosa cell tumors

International Journal of Gynecological Cancer

Volumn 19, Issue 4, 2009, Pages 628-633

  Nosov, Vladimir ^a   Silva, Ivaldo ^b   Tavassoli, Fattaneh ^c   Adamyan, Leiva ^d   Farias Eisner, Robin ^a   Schwartz, Peter E ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c YALE UNIVERSITY MEDICAL CENTER   (United States)

^d RESEARCH CENTER OF OBSTETRICS   (Russian Federation)

Author keywords

Granulosa cell; Marker; Recurrence; Tumor

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; INHIBIN; KI 67 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RISK; CLINICAL STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; FOLLOW UP; GRANULOSA CELL TUMOR; HOSPITAL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUTEINIZATION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MITOSIS INDEX; MORPHOLOGY; MULTIVARIATE ANALYSIS; PATIENT IDENTIFICATION; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; STAINING; TUMOR RECURRENCE; UNIVARIATE ANALYSIS;

COHORT STUDIES; FEMALE; GRANULOSA CELL TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 67651030492     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a48a6f     Document Type: Article

References (29)

1. Fox H, Agrawal K, Langley FA. A clinicopathologic study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis. Cancer. 1975;35:231-241.
2. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21:1180-1189.
3. Bjorkholm E, Silfversward C. Prognostic factors in granulosa-cell tumors. Gynecol Oncol. 1981;11:261-274.
4. Ohel G, Kaneti H, Schenker JG. Granulosa cell tumors in Israel: a study of 172 cases. Gynecol Oncol. 1983;15:278-286.
5. Stenwig JT, Hazekamp JT, Beecham JB. Granulosa cell tumors of the ovary. A clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol. 1979;7:136-152.
6. Lack EE, Perez-Atayde AR, Murthy AS, et al. Granulosa theca cell tumors in premenarchal girls: a clinical and pathologic study of ten cases. Cancer. 1981;48:1846-1854.
7. Young RH, Dickersin GR, Scully RE. Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol. 1984;8:575-596.
8. Biscotti CV, Hart WR. Juvenile granulosa cell tumors of the ovary. Arch Pathol Lab Med. 1989;113:40-46.
9. Evans AT 3rd, Gaffey TA, Malkasian GD Jr, et al. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol. 1980;55:231-238.
10. Gusberg SB, Kardon P. Proliferative endometrial response to theca-granulosa cell tumors. Am J Obstet Gynecol. 1971;111: 633-643.
11. Miller BE, Barron BA, Wan JY, et al. Prognostic factors in adult granulosa cell tumor of the ovary. Cancer. 1997;79:1951-1955.
12. Malmstrom H, Hogberg T, Risberg B, et al. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol. 1994;52: 50-55.
13. Fujimoto N, Sakuragi K, Okuyama T, et al. Histopathological prognostic factors of adult granulosa cell tumors of the ovary. Acta Obstet Gynecol Scand. 2001;80:1069-1074.
14. Sommers SC, Gates O, Goodof II. Late recurrence of granulosa cell tumors; report of two cases. Obstet Gynecol. 1955;6:395-398.
15. Zambetti M, Escobedo A, Pilotti S, et al. Cis-platinum/vinblastine/ bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecol Oncol. 1990;36: 317-320.
16. Savage P, Constenla D, Fisher C, et al. Granulosa cell tumours of the ovary: demographics, survival and the management of advanced disease. Clin Oncol (R Coll Radiol). 1998;10:242-245.
17. Cronje HS, Niemand I, Bam RH, et al. Review of the granulosa-theca cell tumors from the Emil Novak Ovarian Tumor Registry. Am J Obstet Gynecol. 1999;180:323-327.
18. Chan JK, Zhang M, Kaleb V, et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary-a multivariate analysis. Gynecol Oncol. 2005;96:204-209.
19. Pectasides D, Pectasides E, Psyrri A. Granulosa cell tumor of the ovary. Cancer Treat Rev. 2008;34:1-12.
20. Uygun K, Aydiner A, Saip P, et al. Granulosa cell tumor of the ovary: retrospective analysis of 45 cases. Am J Clin Oncol. 2003;26: 517-521.
21. Lauszus FF, Petersen AC, Greisen J, et al. Granulosa cell tumor of the ovary: a population-based study of 37 women with stage I disease. Gynecol Oncol. 2001;81:456-460.
22. Costa MJ, Walls J, Ames P, et al. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Hum Pathol. 1996;27:274-281.
23. Auranen A, Sundström J, Ijäs J, et al. Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature. Int J Gynecol Cancer. 2007;17:1011-1018.
24. Gebhart JB, Roche PC, Keeney GL, et al. Assessment of inhibin and p53 in granulosa cell tumors of the ovary. Gynecol Oncol. 2000;77: 232-236.
25. Horny HP, Marx L, Krober S, et al. Granulosa cell tumor of the ovary. Immunohistochemical evidence of low proliferative activity and virtual absence of mutation of the p53 tumor-suppressor gene. Gynecol Obstet Invest. 1999;47:133-138.
26. Vesco KK, Carney ME. Granulosa cell tumor of the ovary: extensive late recurrence after initial occult microscopic disease. Obstet Gynecol. 2002;99:888-891.
27. Juric G, Zarkovic N, Nola M, et al. The value of cell proliferation and angiogenesis in the prognostic assessment of ovarian granulosa cell tumors. Tumori. 2001;87:47-53.
28. Huang JN, Liu YZ, Zhang XM. Clinical analysis of juvenile ovary granulosa cell tumor. Zhonghua Fu Chan Ke Za Zhi. 2007;42: 533-536.
29. Mom CH, Engelen MJ, Willemse PH, et al. Granulosa cell tumors of the ovary: the clinical value of serum inhibin A and B levels in a large single center cohort. Gynecol Oncol. 2007;105:365-372.